Login  /  Register  /  Search

Medical Alley Association serves the individuals and organizations that comprise Minnesota's health industry by influencing policy, fostering connections and providing critical intelligence to improve the quality of health around the world.

Medical Alley Association serves the individuals and organizations that comprise Minnesota's health industry by influencing policy, fostering connections and providing critical intelligence to improve the quality of health around the world.

Industry Intelligence

Alley Insight: Jobs Are HERE - Average Compensation is $122K

Job Opportunities Abound in Medical Alley The health technology industry in Minnesota’s Medical Alley is a significant contributor to its workforce and economy. In fact, in 2015 a total of 931 firms in the medical device, biopharmaceuticals, diagnos… Read more

Attracting & Retaining Talent for the Minneapolis-Saint Paul Region

Get Engaged. We are looking for company participation in developing a strategy to address the unique talent needs of the health technology industry. To learn more contact Cheryl Matter, cmatter@medicalalley.org. A highly-skilled, highly-productiv… Read more

Talent in Medical Alley

Watch for the 2015 Annual Workforce Report next week! READ THE FULL DOCUMENT Paula J. Norbom, Founder & President, Talencio Talent scarcity is something that we are hearing a lot about these days. According to a Staffing Indust… Read more

Alley Insight: 2015: High Growth in OUS 510(K) Clearances

Download PDF More Information in the 2015 Annual Approval Report Read more

FDA’s Focus on Early Feasibility Studies

The recent FDA strategic priority to increase the number of early feasibility studies (EFS) conducted in the U.S. resulted in dramatic increases in EFS investigational device exemption (IDE) approvals. However, opportunities remain to improve the pro… Read more

Annual Report: Approvals 2015

Key Findings US 510(k) clearances decline 26% in 2015, the lowest in 5 years, while OUS clearances surge 51% China continues trend of steady growth in 510(k) clearances while European and Asian countries see dramatic 2015 spike Cardiology top se… Read more

Thought Leadership: NAMSA

The recent FDA strategic priority to increase the number of early feasibility studies (EFS) conducted in the U.S. resulted in dramatic increases in EFS investigational device exemption (IDE) approvals. However, opportunities remain to improve the pro… Read more
Page 5 of 10